HOME >> BIOLOGY >> NEWS
Novel therapies show promise against myeloid leukemia

(San Diego, Calif., December 6, 2003) Leukemia, a cancer of the white blood cells, starts in the bone marrow but can spread to the blood, lymph nodes, and other organs. Because of its complexity and varying courses in each patient, the development of new and effective treatments for the disease has been challenging for scientists. According to research presented during the 45th Annual Meeting of the American Society of Hematology, novel therapeutic approaches directed against unique targets provide new hope for those suffering from these diseases.

"While the survival rate for leukemia has improved in the past two decades, especially among children, it is still a very difficult disease to treat in adults," said Richard Larson, M.D., University of Chicago Hospital. "New treatments are beginning to improve survival."

Probability and Impact of Obtaining a Cytogenetic Response to Imatinib as Initial Therapy for Chronic Myeloid Leukemia (CML) in Chronic Phase (Abstract 634)

Chronic myeloid leukemia (CML), a malignant cancer of the bone marrow, is one of the most common forms of leukemia. Imatinib (Gleevec), which blocks the abnormal protein driving the overproduction of abnormal white blood cells, has become the standard therapy for patients not undergoing stem cell transplantation. In newly diagnosed patients, researchers are still uncertain about the length of time imatinib should be administered to adequately determine a response. To assist patients and physicians in weighing the risks and benefits of continuing imatinib, this issue was recently examined by researchers from the Oregon Health & Science University Cancer Institute by analyzing data on 553 newly diagnosed chronic phase patients who were treated intitially with imatinib as part of a multi-national study that compared imatinib to interferon+Ara-C (cytosine arabinoside, the previous standard therapy for CML).

Scientists
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
6-Dec-2003


Page: 1 2 3 4 5 6

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel sensors help clear the air
5. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
6. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
7. Novel therapeutic target identified in fight against Rheumatoid Arthritis
8. Novel bacterium detoxifies chlorinated pollutants
9. Novel flu vaccine shows promise in mice
10. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... 04, 2019 , ... Molecular Devices, a global leader in ... new President of Molecular Devices, replacing Greg Milosevich who has been appointed President ... Since joining Molecular Devices in a scientific engineering role, Ms. Murphy has held ...
(Date:6/1/2019)... ... May 31, 2019 , ... The ... Rosati recently invested in BioFactura’s $6M Series B Financing Round. , “With ... institutional investors who bring significant financial and business resources to bear as we ...
(Date:5/31/2019)... ... May 31, 2019 , ... The OilComm Conference ... TX, announced today that Ben Reiter, Senior Writer at Sports Illustrated and Author ... 3rd.     , Reiter predicted the Houston Astros would win the MLB championship in ...
Breaking Biology News(10 mins):
(Date:6/12/2019)... (PRWEB) , ... June 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... Zillion has been signed. The agreement will grant exclusive rights for Zillion to ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... will add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed ... DeepDyve’s continually expanding library of more than 20 million articles, sourced from more ...
(Date:6/11/2019)... ... 2019 , ... A study released today in STEM CELLS ... to incorporate into human CD34+ cells, modifying their gene expression and increasing their ... cells’ ability to lodge into bone marrow. This research performed by Prof. Sanchez-Guijo’s ...
(Date:5/31/2019)... California (PRWEB) , ... May ... ... of our patent applications from the USPTO providing proprietary interest to our ... METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including ...
Breaking Biology Technology:
Cached News: